Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Other financing activities (2016 - 2025)

Surgery Partners' Other financing activities history spans 11 years, with the latest figure at $2.4 million for Q4 2025.

  • For Q4 2025, Other financing activities rose 168.57% year-over-year to $2.4 million; the TTM value through Dec 2025 reached $4.1 million, up 132.54%, while the annual FY2025 figure was $4.1 million, 132.54% up from the prior year.
  • Other financing activities for Q4 2025 was $2.4 million at Surgery Partners, up from $1.7 million in the prior quarter.
  • Across five years, Other financing activities topped out at $16.7 million in Q2 2021 and bottomed at -$13.2 million in Q4 2023.
  • The 5-year median for Other financing activities is -$1.6 million (2024), against an average of -$635000.0.
  • The largest annual shift saw Other financing activities soared 5666.67% in 2021 before it tumbled 555.17% in 2023.
  • A 5-year view of Other financing activities shows it stood at $9.3 million in 2021, then crashed by 68.82% to $2.9 million in 2022, then crashed by 555.17% to -$13.2 million in 2023, then surged by 73.48% to -$3.5 million in 2024, then soared by 168.57% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Other financing activities are $2.4 million (Q4 2025), $1.7 million (Q3 2025), and -$1.7 million (Q2 2025).